Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters

Database
Language
Document Type
Year range
1.
Eur J Ophthalmol ; 31(2): NP4-NP7, 2021 Mar.
Article in English | MEDLINE | ID: covidwho-947912

ABSTRACT

The Coronavirus disease 2019 (COVID-19) outbreak has imposed the adoption of strategies to limit the risk of contagion for cancer patients without compromising their healthcare. As well as cancers of other sites, the treatment of certain ocular and periocular malignancies is considered non-deferrable and should proceed despite the pandemic. Delays in treatment of these patients may result in negative outcomes. Herein, we provide some practical considerations deriving from our experience at the Ocular Oncology Unit of Careggi University Hospital (Florence, Italy).


Subject(s)
COVID-19/epidemiology , Delivery of Health Care/organization & administration , Eye Neoplasms/diagnosis , Eye Neoplasms/therapy , Hospitals, University/organization & administration , Medical Oncology/organization & administration , SARS-CoV-2 , Disease Outbreaks , Humans , Italy/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL